John R. Plachetka

1.1k total citations
37 papers, 847 citations indexed

About

John R. Plachetka is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, John R. Plachetka has authored 37 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 10 papers in Pharmacology. Recurrent topics in John R. Plachetka's work include Anesthesia and Sedative Agents (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Inflammatory mediators and NSAID effects (7 papers). John R. Plachetka is often cited by papers focused on Anesthesia and Sedative Agents (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Inflammatory mediators and NSAID effects (7 papers). John R. Plachetka collaborates with scholars based in United States and Canada. John R. Plachetka's co-authors include Donna Gutterman, Jane T. Osterhaus, Jack G. Copeland, Neal W. Salomon, Douglas F. Larson, John B. Leslie, Nicholas M. P. King, W. David Watkins, J. Edward Jackson and Arnold M. Epstein and has published in prestigious journals such as Gastroenterology, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

John R. Plachetka

36 papers receiving 770 citations

Peers

Countries citing papers authored by John R. Plachetka

Since Specialization

Citations

This map shows the geographic impact of John R. Plachetka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Plachetka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Plachetka more than expected).

Fields of papers citing papers by John R. Plachetka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Plachetka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Plachetka. The network helps show where John R. Plachetka may publish in the future.

Co-authorship network of co-authors of John R. Plachetka

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Plachetka. A scholar is included among the top collaborators of John R. Plachetka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Plachetka. John R. Plachetka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacodynamic Evaluation of Clopidogrel Plus PA32540: The Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) Study 2011 ·Clinical Pharmacology & Therapeutics ·Paul A. Gurbel, Kevin P. Bliden, John G. Fort, (unknown), John R. Plachetka, Mark J. Antonino, Martin G. Gesheff, Udaya S. Tantry	6
2	Clinical trial: evaluation of gastric acid suppression with three doses of immediate‐release esomeprazole in the fixed‐dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric‐coated esomeprazole 20 mg: a randomized, open‐label, Phase I study in healthy volunteers 2010 ·Alimentary Pharmacology & Therapeutics ·Philip B. Miner, John R. Plachetka, (unknown), John G. Fort, Mark Sostek	18
3	Analgesic doses of aspirin (ASA) cause significant upper gastrointestinal (UGI) damage: PA65020, a new combination of enteric-coated aspirin (EC-ASA) & immediate-release (IR) omeprazole significantly reduces the incidence of gastroduodenal ulcers (GU/DU) 2010 ·Journal of Pain ·John G. Fort, (unknown), (unknown), John R. Plachetka	1
4	T1972 Pharmacokinetics of Naproxen and Esomeprazole in PN400, a Single-Tablet, Multilayer Formulation of Enteric-Coated Naproxen Coupled with Immediate-Release Esomeprazole 2009 ·Gastroenterology ·Philip B. Miner, John R. Plachetka, (unknown), John G. Fort, Mark Sostek	1
5	T1969 Gastric Acid Suppression with PN400, a Single-Tablet, Multilayer, Fixed-Dose Formulation Combining An Immediate-Release Esomeprazole Layer and An Enteric-Coated (EC) Naproxen Core 2009 ·Gastroenterology ·Philip B. Miner, John R. Plachetka, (unknown), John G. Fort, Mark Sostek	1
6	116 A Single Tablet Multilayer Formulation of Enteric-Coated Naproxen Coupled with Non-Enteric-Coated OMEPRAZOLE Is Associated with a Significantly Reduced Incidence of Gastric Ulcers vs. Enteric-Coated Naproxen: A Prospective, Randomized, Double-Blind Study 2008 ·Gastroenterology ·Jay L. Goldstein, Mark Sostek, John G. Fort, Dennis Riff, Ying Zhang, John R. Plachetka	2
7	Integrated gastric acidity can predict the prevention of naproxen-induced gastroduodenal pathology in normal subjects 2003 ·Gastroenterology ·John R. Plachetka, (unknown), (unknown), Julie Borland, (unknown), (unknown), Jerry D. Gardner	9
8	931-111 Platelet Activation and Aggregation by Therapeutic Doses of Heparin 1995 ·Journal of the American College of Cardiology ·Zihui Xiao, Pierre Théroux, John R. Plachetka	4
9	Healthcare Resource and Lost Labour Costs of Migraine Headache in the US 1992 ·PharmacoEconomics ·Jane T. Osterhaus, Donna Gutterman, John R. Plachetka	294
10	Health-Related Quality of Life Among Patients Undergoing Percutaneous Transluminal Coronary Angioplasty 1991 ·Medical Care ·Paul D. Cleary, Arnold M. Epstein, Gerry Oster, (unknown), William B. Stason, (unknown), John R. Plachetka, Mark Zimmerman	54
11	Attenuation of the hemodynamic responses to endotracheal intubation with preinduction intravenous labetalol 1989 ·Journal of Clinical Anesthesia ·John B. Leslie, (unknown), Thomas M McLoughlin, John R. Plachetka	27
12	Evaluation of the Pharmacokinetics and Safety of Ascending Single Oral Doses of GR43175 Administered to Healthy Male Volunteers 1989 ·Cephalalgia ·M. A. Busch, John R. Plachetka, (unknown), (unknown), (unknown), Philip T. Leese	5
13	Hemodynamic Effects of Labetalol in Young and Older Adult Hypertensives 1988 ·The Journal of Clinical Pharmacology ·James C. Buell, Robert S. Eliot, John R. Plachetka, Mark Little	13
14	Interindividual and Intraindividual Variability in Labetalol Pharmacokinetics 1988 ·The Journal of Clinical Pharmacology ·Walid M. Awni, Debra J. Skaar, Michael H. Schwenk, (unknown), John R. Plachetka, Gary R. Matzke	9
15	Labetalol in the Treatment of Hypertension in Elderly and Younger Patients 1987 ·The Journal of Clinical Pharmacology ·Nicholas M. P. King, (unknown), John R. Plachetka	14
16	Comparison in young and elderly patients of pharmacodynamics and disposition of labetalol in systemic hypertension 1987 ·The American Journal of Cardiology ·Nicholas M. P. King, Janice B. Schwartz, John R. Plachetka, Elizabeth L. Todd, JM Egan	30
17	Lack of Effect of Histamine H₂‐Receptor Antagonists on Indocyanine Green Disposition Measured by Two Methods 1984 ·The Journal of Clinical Pharmacology ·(unknown), J. Robert Powell, John F. Rogers, John R. Plachetka	28
18	The Effects of Antacid and Propantheline on the Absorption of Oral Ranitidine 1984 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Fred N. Eshelman, John R. Plachetka, Louis F. Fabre, J. Robert Powell	2
19	Inaccuracy of pulmonary capillary wedge pressure when compared to left atrial pressure in the early postsurgical period 1982 ·Journal of Thoracic and Cardiovascular Surgery ·Robert B. Mammana, (unknown), Sidney Levitsky, Paul Thomas, John R. Plachetka	32
20	More on Cimetidine — Theophylline Interaction 1981 ·Drug Intelligence & Clinical Pharmacy ·J. Edward Jackson, John R. Plachetka	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact